Advertisement

Topics

Companies Related to "The Protective Immune Response to Attenuated Enterotoxigenic Escherichia Coli Infection" [Most Relevant Company Matches] RSS

11:14 EST 16th February 2019 | BioPortfolio

Here are the most relevant search results for "The Protective Immune Response to Attenuated Enterotoxigenic Escherichia Coli Infection" found in our extensive corporate database of over 50,000 company records.

Showing "Protective Immune Response Attenuated Enterotoxigenic Escherichia Coli Infection" Companies 1–25 of 1,200+

Extremely Relevant

Vivaldi Biosciences Inc.

Vivaldi Biosciences is developing live attenuated influenza vaccines (LAIVs) with the potential for increased effectiveness in the prevention of emerging pandemic influenza and seasonal influenza. Vivaldi’s LAIVs are designed using proprietary reverse genetics and plasmid rescue technologies to truncate the influenza NS1 gene. The unique method of att...


Relevant

Advaxis, Inc. and Rodman & Renshaw, LLC

Advaxis is a biotechnology company developing the next generation of immunotherapies for cancer and infectious diseases. Advaxis immunotherapies are based on a novel platform technology using live attenuated Listeria monocytogenes (Lm) that are bio-engineered to secrete an antigen/adjuvant fusion protein that redirects the powerful immune response all huma...

Telephus Medical LLC

Telephus Medical, located in San Diego, California, is developing a suite of monoclonal antibody products designed to neutralize key staphylococcal enzymes used to attach to host tissues, replicate and evade immune attack. These enzymes, are central components of the bacterial machinery staphylococci utilize to invade host tissues, evade the immune respons...


Iomai

Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called transcutaneous immunization (TCI). TCI taps into the unique benefits of a major group of antigen-presenting cells found in the outer layers of the skin to generate an enhanced immune response. Iomai is leveraging TCI to enhance the efficacy of existing vaccines, en...

FlowMetric Diagnostics Inc.

FlowMetric Diagnostics, an affiliate of FlowMetric Inc., based in Doylestown, PA and founded in December 2013, utilizes a flow cytometry-based platform to analyze cell-mediated immune responses. The company’s proprietary assays require only small volumes of capillary blood, eliminating the need for venous blood draw. The technology can be readily adap...

Immunetics, Inc.

Immunetics has pioneered the use of the C6 peptide, a 26-amino acid sequence within the Borrelia membrane protein VlsE. This is the first truly specific and sensitive marker for infection with the Borrelia burgdorferi spirochete. The C6 peptide sequence is highly antigenic, generating an immune response in nearly all human cases soon after infection, and it is specific to Borrelia strains causing ...

The Immune Response Corporation

The Immune Response Corporation (OTCBB: IMNR.OB) is an immuno-pharmaceutical company focused on developing products to treat autoimmune and infectious diseases. The Company’s lead immune-based therapeutic product candidates are NeuroVax™ for the treatment of MS and IR103 for the treatment of HIV infection. Both of these therapies are in Phase II clinical development and are designed to stimula...

World of Health Biotech Co.Ltd

Anti HBV Specific Active Immunotherapy (Anti HBV Therapeutic Vaccine) using recombinant hepatitis B vaccine (standard HBV vaccine) as an immunogenic specific antigen and several cytokines as an immune adjuvant is a new antiviral approach for chronic HBV infection. The first and most critical setp in the design of an anti HBV therapeutic vaccine is the selection of the specific antigens that will b...

Protective Life Corporation

Protective Life Corporation provides financial services through the production, distribution and administration of insurance and investment products throughout the U.S. The company traces its roots to the corporation’s flagship company, Protective Life Insurance Company – founded in 1907. Throughout its more than 110-year history, Protective’s ...

Immunitor Corporation Co., Ltd

Immunitor Corporation Co., Ltd., is the first private biotech company formed in Thailand Technology developed by Immunitor allows to formulate any desired immunogen or antigen as an oral tablet.Such antigens are formulated into an ordinary appearing pill in such a way that they can withstand the digestive degradation in the stomach but are capable to trigger immune response once pr...

Affinivax Inc.

Affinivax is advancing a next generation conjugate vaccine technology platform to enable the development of vaccines that provide the highest level of protection against challenging infectious diseases. Backed by an investment from the Bill & Melinda Gates Foundation and working with world experts in vaccine discovery and development, Affinivax is focused ...

Inotrem S.A.

Inotrem is a biotechnology company specialized in the control of excessive immune response that occurs in acute inflammatory syndromes in the critical care setting. It has developed a new concept of immunomodulation to control abnormal immune response to tissue injuries, using a personalized medicine approach. The Company has been founded in 2013 in Nancy ...

AGY Therapeutics Incorporated

AGY is an emerging biopharmaceutical company, discovering and developing novel treatments for diseases of the nervous system. AGY scientists have established and utilized a unique mechanism-based approach to identify and characterize new molecules for disease intervention. The intricate molecular networks activated by stress, injury, infection, degeneration and toxins offer a unique basis for sele...

Checkmate Pharmaceuticals, Inc.

Checkmate Pharmaceuticals is a research and development company pursuing a novel approach to specifically activating the innate arm of the immune system to recognize and ultimately destroy tumor cells. The company is leveraging their expertise and the vast body of knowledge in the field of CpG oligonucleotides and is validating an approach that will combine ...

IRX Therapeutics, Inc.

IRX Therapeutics is a clinical-stage company developing novel immunotherapies focused on reducing the immune suppression that is seen in the cancer tumor micro-environment, restoring immune function, and activating a coordinated immune response against the tumor. The lead candidate, IRX-2, is a proprietary therapeutic containing numerous active cytokine co...

The FlowMetric Family of Companies

The FlowMetric Family of Companies consist of FlowMetric, Inc. and two additional affiliate companies, FlowMetric Europe, S.p.A. and FlowMetric Diagnostics, Inc. FlowMetric, Inc. and FlowMetric Europe, S.p.A., founded in 2010 and 2013 respectively, are niche contract research organizations (CROs), focused on providing polychromatic flow cytometry and cell ...

Pharmexa A/S

Pharmexa is a leading company in the field of therapeutic vaccines (pharmaccines) for the treatment of serious chronic diseases. Pharmexa’s proprietary AutoVac™ pharmaccine technology platform is broadly applicable, but the company currently focuses its resources on a number of cancer forms and chronic inflammatory diseases. Pharmexa´s product pipeline targets breast cancer, rheumatoid arthri...

Professor Ona's laboratory at Kyushu University

Started in beginning of 2002, Professor Ona's laboratory develops original theories, instruments and applications concerning human health, ES cell differentiation, aquaculture, environment and food security. The research achievements except above are as follows.1. Non-invasive prediction of next or final differentiation status of ES cell at the initiation ...

Bonature Inc.

Bonature Inc. is a biotechnology R&D company which focuses on protein drugs and molecular biology kits. Currently, the company has one immunomodulatory drug candidate in the in vitro and in vivo research. Some animal tests has been done and revealed positive results for anti-infection. We also have a product 1-min E. coli competent cells for plasmid transformation, which allows researchers complet...

PIN Pharma, Inc.

PIN Pharma is a pre-IND stage venture backed immunotherapy company focused on the development of PINS (precision immune stimulants). The lead compound PIN-2 is a first-in-class, novel, next-generation engineered peptide that empowers the immune system in vivo. The Company’s technology primes the innate immune system to modulate adaptive immunity there...

Sanaria Inc.

Sanaria Inc. was founded in 2003. The company's primary mission is to develop and commercialize attenuated whole-parasite malaria vaccines that confer high-level, long-lasting protection against Plasmodium falciparum, the parasite responsible for most of the malaria-associated severe illness and death worldwide. Sanaria's radiation attenuated sporozoite vaccine, Sanaria(TM) PfSPZ Vaccine, entered...

Biothera Pharmaceuticals, Inc.

Biothera is a privately held biotechnology company developing Imprime PGG, a clinical stage immunotherapy drug that modulates key immune cells to orchestrate a coordinated immune response to cancer that involves both the innate and adaptive immune system. Proof of concept has been established from single-arm and randomized phase 2 studies in non-small cell...

Aduro BioTech, Inc.

Aduro BioTech is a clinical-stage immunotherapy company with a platform technology for therapeutic and prophylactic vaccines for cancer and infectious diseases. The platform of attenuated and targeted vaccines based on Listeria monocytogenes has been in development for 9 years and has been validated by more than 20 major publications and more than $20 mill...

Affinivax, Inc.

Affinivax is advancing a next generation vaccine technology platform to enable the development of vaccines that provide the highest level of protection against challenging infectious diseases. Backed by an investment from the Bill & Melinda Gates Foundation, and working with world experts in vaccine discovery and development, Affinivax is focused on creati...

ENBREL

ENBREL is a type of protein called a tumor necrosis factor (TNF) blocker that blocks the action of a substance your body's immune system makes called TNF. People with an immune disease, such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and psoriasis, have too much TNF in their bodies. ENBREL can reduce the amount of TNF in the body to normal levels, helping to treat your d...


More From BioPortfolio on "The Protective Immune Response to Attenuated Enterotoxigenic Escherichia Coli Infection"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks